Board meeting on 2 November 2026 to consider Q2 and H1 results
Epigral Ltd has informed the exchanges that its Board of Directors will meet on Monday, 2nd November, 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Monday, 2nd November, 2026
- Results Period
- second quarter and half year ended 30th September, 2026
- Venue
- Registered Office of the Company
Why this update matters
This is a formal notice telling shareholders when the company's next set of numbers will be considered by its Board. It does not contain any financial results, guidance or business update by itself. It only sets the date on which those numbers are expected to be approved and taken on record.
What the Board will consider
- Un-Audited Financial Results, both Standalone and Consolidated, for the Second Quarter and Half Year ended 30th September, 2026.
- To take on record the Limited Review Report of the Statutory Auditors on those results.
- Any other business with the permission of the Chair.
Key details given
- Meeting date: Monday, 2nd November, 2026.
- Venue: the Registered Office of the Company.
- The intimation has been given to both the National Stock Exchange (symbol: EPIGRAL) and BSE Limited (Scrip Code: 543332).
How to read this
A board meeting notice of this kind is routine. Its main use for a retail investor is as a calendar marker: the quarterly and half-yearly results are scheduled to be placed before the Board on that date. The actual performance figures, segment details, margins and any commentary come only with the results themselves, not with this notice.
What to watch for next
Once the results are approved, the company typically publishes the standalone and consolidated statements along with the auditors' limited review report. Those documents, not this notice, will carry the numbers that matter for judging the quarter.
Please note: the update confirms that the auditors' Limited Review Report will be taken on record at the same meeting; it does not contain the contents of that report.
Also from Epigral
CRISIL AA/Stable and CRISIL A1+ assigned as revised ratings on Rs. 1050 Crore bank facilities
29 Oct 2026
Income-tax assessment order with notice of demand of Rs.28.11 crore
29 Oct 2026
Epigral schedules conference call for 2 November 2026 to discuss Q2 FY27 results
28 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.